Elite Pharmaceuticals, Inc. (ELTP) News
Follow Elite Pharmaceuticals, Inc. (ELTP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript
Elite Pharmaceuticals (OTC: ELTP ) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and
EARNINGS | Jul 02, 2026, 11:57 AM UTC
H
Elite Pharmaceuticals Q4 EPS $0.01 Down From $0.02 YoY, Sales $40.748M Up From $31.996M YoY
Elite Pharmaceuticals (OTC: ELTP ) reported quarterly earnings of $0.01 per share. This is a 50 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $40.748 million in sa
EARNINGS | Jun 29, 2026, 09:11 PM UTC